{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:17:27Z","timestamp":1779214647436,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-024-03107-8","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T06:01:56Z","timestamp":1713247316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Changes in ocular blood flow in patients with neovascular age-related macular degeneration after intravitreal injection of ranibizumab biosimilar and brolucizumab"],"prefix":"10.1007","volume":"44","author":[{"given":"Hiroki","family":"Takizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsu","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kunikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"3107_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106\u2013e116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1","journal-title":"Lancet Glob Health"},{"key":"3107_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.gendis.2021.02.009","volume":"9","author":"Y Deng","year":"2022","unstructured":"Deng Y, Qiao L, Du M, Qu C, Wan L, Li J, Huang L (2022) Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy. Genes Dis 9:62\u201379. https:\/\/doi.org\/10.1016\/j.gendis.2021.02.009","journal-title":"Genes Dis"},{"key":"3107_CR3","first-page":"3158","volume":"41","author":"N Kwak","year":"2000","unstructured":"Kwak N, Okamoto N, Wood JM, Campochiaro PA (2000) VEGF Is Major Stimulator in Model of Choroidal Neovascularization. Invest Ophthalmol Vis Sci 41:3158\u20133164","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3107_CR4","doi-asserted-by":"publisher","first-page":"H1054","DOI":"10.1152\/ajpheart.1998.274.3.H1054","volume":"274","author":"JD Hood","year":"1998","unstructured":"Hood JD, Meininger CJ, Ziche M, Granger HJ (1998) VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol Heart Circ Physiol 274:H1054\u2013H1058. https:\/\/doi.org\/10.1152\/ajpheart.1998.274.3.H1054","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3107_CR5","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.ophtha.2016.03.045","volume":"123","author":"MG Maguire","year":"2016","unstructured":"Maguire MG, Martin DF, Ying GS, Jaffe GJ, Daniel E, Grunwald JE, Toth CA, Ferris FL 3rd, Fine SL (2016) Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: the comparison of age-related macular degeneration treatments trials. Ophthalmology 123:1751\u20131761. https:\/\/doi.org\/10.1016\/j.ophtha.2016.03.045","journal-title":"Ophthalmology"},{"key":"3107_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00417-020-05024-9\/Published","volume":"259","author":"H Hosseini","year":"2021","unstructured":"Hosseini H, Rabina G, Pettenkofer M, Au A, Chehaibou I, Heilweil G, Weiner AJ, Ip M, Loewenstein A, Schwartz SD (2021) Clinical characteristics and visual outcomes of non-resolving subretinal fluid in neovascular AMD despite continuous monthly anti-VEGF injections: a long-term follow-up. Graefes Arch Clin Exp Ophthalmol 259:1153\u20131160. https:\/\/doi.org\/10.1007\/s00417-020-05024-9\/Published","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3107_CR7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.18502\/jovr.v15i3.7452","volume":"15","author":"A Lee","year":"2020","unstructured":"Lee A, Garg PG, Lyon AT, Mirza R, Gill MK (2020) Long-term outcomes of treat and extend regimen of anti-vascular endothelial growth factor in neovascular age-related macular degeneration. J Ophthalmic Vis Res 15:331\u2013340. https:\/\/doi.org\/10.18502\/jovr.v15i3.7452","journal-title":"J Ophthalmic Vis Res"},{"key":"3107_CR8","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1172\/JCI119868","volume":"100","author":"A Papapetropoulos","year":"1997","unstructured":"Papapetropoulos A, Garc\u00eda-Carde\u00f1a G, Madri JA, Sessa WC (1997) Nitric oxide mediates the actions of VEGF nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100:3131\u20133139. https:\/\/doi.org\/10.1172\/JCI119868","journal-title":"J Clin Invest"},{"key":"3107_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s12886-022-02700-8","volume":"22","author":"MD Resch","year":"2022","unstructured":"Resch MD, Balogh A, Kurth T, Nagy ZZ, DeBuc DC, Papp A (2022) Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections. BMC Ophthalmol 22:469. https:\/\/doi.org\/10.1186\/s12886-022-02700-8","journal-title":"BMC Ophthalmol"},{"key":"3107_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/bjophthalmol-2019-313919","volume":"104","author":"AS Mursch-Edlmayr","year":"2020","unstructured":"Mursch-Edlmayr AS, Luft N, Podkowinski D, Ring M, Schmetterer L, Bolz M (2020) Effects of three intravitreal injections of aflibercept on the ocular circulation in eyes with age-related maculopathy. Br J Ophthalmol 104:53\u201357. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-313919","journal-title":"Br J Ophthalmol"},{"key":"3107_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2022-001205","volume":"8","author":"A Hatamnejad","year":"2023","unstructured":"Hatamnejad A, Dadak R, Orr S, Wykoff C, Choudhry N (2023) Systematic review of efficacy and meta-analysis of safety of ranibizumab biosimilars relative to reference ranibizumab anti-VEGF therapy for nAMD treatment. BMJ Open Ophthalmol 8:e001205. https:\/\/doi.org\/10.1136\/bmjophth-2022-001205","journal-title":"BMJ Open Ophthalmol"},{"key":"3107_CR12","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1111\/aos.13763","volume":"96","author":"B Mottet","year":"2018","unstructured":"Mottet B, Aptel F, Geiser MH, Hera R, Zhou T, Almanjoumi A, Vinh V, Chiquet C (2018) Choroidal blood flow after the first intravitreal ranibizumab injection in neovascular age-related macular degeneration patients. Acta Ophthalmol 96:e783\u2013e788. https:\/\/doi.org\/10.1111\/aos.13763","journal-title":"Acta Ophthalmol"},{"key":"3107_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ophtha.2019.12.031","volume":"127","author":"QD Nguyen","year":"2020","unstructured":"Nguyen QD, Das A, Do DV, Dugel PU, Gomes A, Holz FG, Koh A, Pan CK, Sepah YJ, Patel N, MacLeod H, Maurer P (2020) Brolucizumab: Evolution through preclinical and clinical studies and the implications for the management of neovascular age-related macular degeneration. Ophthalmology 127:963\u2013976. https:\/\/doi.org\/10.1016\/j.ophtha.2019.12.031","journal-title":"Ophthalmology"},{"key":"3107_CR14","first-page":"593","volume":"129","author":"PU Dugel","year":"2021","unstructured":"Dugel PU, Singh RP, Koh A, Ogura Y, Weissgerber G, Gedif K, Jaffe GJ, Tadayoni R, Schmidt-Erfurth U, Holz FG (2021) HAWK and HARRIER: 96\u00a0week outcomes from the phase 3 trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology 129:593\u2013596","journal-title":"Ophthalmology"},{"key":"3107_CR15","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ophtha.2015.12.030","volume":"123","author":"FG Holz","year":"2016","unstructured":"Holz FG, Dugel PU, Weissgerber G, Hamilton R, Silva R, Bandello F, Larsen M, Weichselberger A, Wenzel A, Schmidt A, Escher D, Sararols L, Souied E (2016) Single-Chain antibody fragment VEGF Inhibitor RTH258 for neovascular age-related macular degeneration: a randomized controlled study. Ophthalmology 123:1080\u20131089","journal-title":"Ophthalmology"},{"key":"3107_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.21037\/aes-21-41","volume":"6","author":"F Pignatelli","year":"2021","unstructured":"Pignatelli F, Niro A, Passidomo F, Addabbo G (2021) Molecular structure, pharmacokinetics and clinical evidence of brolucizumab: a narrative review. Ann Eye Sci 6:37. https:\/\/doi.org\/10.21037\/aes-21-41","journal-title":"Ann Eye Sci"},{"key":"3107_CR17","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s0039-6257(05)80092-x","volume":"39","author":"A Bird","year":"1995","unstructured":"Bird A, Bressler N, Bressler S, Chisholm IH, Coscas G, Davis MD, de Jong PT, Klaver CC, Klein BE, Klein R et al (1995) An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM epidemiological study group. Surv Ophthalmol 39:367\u2013374. https:\/\/doi.org\/10.1016\/s0039-6257(05)80092-x","journal-title":"Surv Ophthalmol"},{"key":"3107_CR18","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/ceo.13837","volume":"48","author":"R Guymer","year":"2020","unstructured":"Guymer R, Wu Z (2020) Age-related macular degeneration (AMD): more than meets the eye. The role of multimodal imaging in today\u2019s management of AMD-A review. Clin Exp Ophthalmol 48:983\u2013995. https:\/\/doi.org\/10.1111\/ceo.13837","journal-title":"Clin Exp Ophthalmol"},{"key":"3107_CR19","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1167\/iovs.18-23872","volume":"59","author":"N Kiyota","year":"2018","unstructured":"Kiyota N, Shiga Y, Ichinohasama K, Yasuda M, Aizawa N, Omodaka K, Honda N, Kunikata H, Nakazawa T (2018) The impact of intraocular pressure elevation on optic nerve head and choroidal blood flow. Invest Ophthalmol Vis Sci 59:3488\u20133496. https:\/\/doi.org\/10.1167\/iovs.18-23872","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3107_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1755-3768.2009.01586.x","volume":"88","author":"T Sugiyama","year":"2010","unstructured":"Sugiyama T, Araie M, Riva CE, Schmetterer L, Orgul S (2010) Use of laser speckle flowgraphy in ocular blood flow research. Acta Ophthalmol 88:723\u2013729. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01586.x","journal-title":"Acta Ophthalmol"},{"key":"3107_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1081\/BIP-100104194","volume":"11","author":"CH Mallinckrodt","year":"2001","unstructured":"Mallinckrodt CH, Clark WS, David SR (2001) Accounting for dropout bias using mixed-effects models. J Biopharm Stat 11:9\u201321. https:\/\/doi.org\/10.1081\/BIP-100104194","journal-title":"J Biopharm Stat"},{"key":"3107_CR22","unstructured":"Lenth RV (2023) emmeans: estimated marginal means, aka least-squares means. The comprehensive R archive network. https:\/\/CRAN.R-project.org\/package=emmeans. Accessed 11 January 2024"},{"key":"3107_CR23","unstructured":"Posit team (2023) RStudio: integrated development environment for R. Posit. https:\/\/posit.co\/downloads\/. Accessed 11 January 2024"},{"key":"3107_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10792-020-01562-7","volume":"41","author":"T Asano","year":"2021","unstructured":"Asano T, Kunikata H, Yasuda M, Nishiguchi KM, Abe T, Nakazawa T (2021) Ocular microcirculation changes, measured with laser speckle flowgraphy and optical coherence tomography angiography, in branch retinal vein occlusion with macular edema treated by ranibizumab. Int Ophthalmol 41:151\u2013162. https:\/\/doi.org\/10.1007\/s10792-020-01562-7","journal-title":"Int Ophthalmol"},{"key":"3107_CR25","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1167\/iovs.14-14116","volume":"55","author":"Y Shiga","year":"2014","unstructured":"Shiga Y, Asano T, Kunikata H, Nitta F, Sato H, Nakazawa T, Shimura M (2014) Relative flow volume, a novel blood flow index in the human retina derived from laser speckle flowgraphy. Invest Ophthalmol Vis Sci 55:3899\u20133904. https:\/\/doi.org\/10.1167\/iovs.14-14116","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3107_CR26","doi-asserted-by":"publisher","first-page":"23723","DOI":"10.1038\/s41598-021-03179-x","volume":"11","author":"G Calzetti","year":"2021","unstructured":"Calzetti G, Mora P, Borrelli E, Sacconi R, Ricciotti G, Carta A, Gandolfi S, Querques G (2021) Short-term changes in retinal and choroidal relative flow volume after anti-VEGF treatment for neovascular age-related macular degeneration. Sci Rep 11:23723. https:\/\/doi.org\/10.1038\/s41598-021-03179-x","journal-title":"Sci Rep"},{"key":"3107_CR27","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1007\/s10792-023-02870-4","volume":"43","author":"K Hoshi","year":"2023","unstructured":"Hoshi K, Kunikata H, Aizawa N, Yasuda M, Okabe T, Takizawa H, Abe T, Nakazawa T (2023) Baseline characteristics associated with the incidence of intraocular inflammation after the intravitreous injection of brolucizumab. Int Ophthalmol 43:4701\u20134709. https:\/\/doi.org\/10.1007\/s10792-023-02870-4","journal-title":"Int Ophthalmol"},{"key":"3107_CR28","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2147\/OPTH.S407249","volume":"17","author":"N Kato","year":"2023","unstructured":"Kato N, Haruta M, Furushima K, Arai R, Matsuo Y, Yoshida S (2023) Decrease in ocular blood flow 30\u00a0minutes after intravitreal injections of brolucizumab and aflibercept for neovascular age-related macular degeneration. Clin Ophthalmol 17:1187\u20131192. https:\/\/doi.org\/10.2147\/OPTH.S407249","journal-title":"Clin Ophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03107-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-024-03107-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-024-03107-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:45:28Z","timestamp":1741880728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-024-03107-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3107"],"URL":"https:\/\/doi.org\/10.1007\/s10792-024-03107-8","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article. Thus, the authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"181"}}